Rising medical expenditures, increasingly stringent healthcare regulations, and growing demand for both disposable and increasingly complex medical devices are all driving healthcare OEMs and fabricators to seek versatile, new material technologies. According to Dow Corning (Midland, MI), a global leader in silicones and silicon-based technology and innovation for the medical device industry, these converging trends are accelerating worldwide demand for its portfolio of high-performance liquid silicone rubber (LSR) materials. These include its biomedical-grade Silastic LSRs, Dow Corning Class VI C6 LSRs, the Dow Corning QP1 LSR product family launched in 2012, and its upcoming Dow Corning QP1-2XX LSR line planned for launch early next year.
According to market research firm Freedonia, the medical industry is among the fastest growing markets for silicone materials. LSRs are attracting particular interest in this segment for their ease of processing and ability to form high-precision parts. In addition to delivering all of these qualities, Dow Corning's QP1 L